Australia’s vibrant business landscape offers great potential for companies in almost all sectors and industries to grow. With a robust economy and a supportive investment climate, most Australian companies have leveraged different avenues to secure funds for their ventures through capital raises. Capital raisings come in a variety of different formats. Whether it’s accessing public
Read More
This quarter has been a busy one for Australian cannabis distributor Cann Group (ASX: CAN), evident in the Company’s sales revenue figures increasing a tidy 91% from the same quarter last year. But with the release of disappointing trial results following its CBD placebo-controlled study, the Company has had to work against a backdrop of
Read More
Have you ever wanted to paint your walls or pull the weeds out of your garden, and you just can’t be stuffed? Australia’s No.1 marketplace for local services, Airtasker (ASX: ART), allows you to delegate your laziness for a fee to strangers that want to get the job done for you, basically the Uber of
Read More
There has been a monumental shift within the buy now, pay later scene with companies consolidating in a recent blitz of mergers and acquisitions. Confidence in this sector has been diminishing as big players like Z1P (ASX: Z1P) have come back to earth, falling as much as 90% since their all-time highs. Following the Block
Read More
When the University of Rochester came knocking on the door of biopharmaceutical company Pharmaxis (ASX: PXS), it was a boost from a respected group of researchers for their lead drug candidate PXS-5505 which has continued to draw attention from around the world. By agreement with Pharmaxis, the University of Rochester embarked on preclinical work on
Read More